OCOGVEP Trademark

Trademark Overview


On Saturday, September 24, 2022, a trademark application was filed for OCOGVEP with the United States Patent and Trademark Office. The USPTO has given the OCOGVEP trademark a serial number of 79354826. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The OCOGVEP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevent...
ocogvep

General Information


Serial Number79354826
Word MarkOCOGVEP
Filing DateSaturday, September 24, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256828
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Monday, April 8, 2024FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 8, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, August 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2023REFUSAL PROCESSED BY IB
Monday, February 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 27, 2023REFUSAL PROCESSED BY MPU
Friday, January 20, 2023ASSIGNED TO EXAMINER
Saturday, December 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Friday, December 30, 2022ASSIGNED TO EXAMINER
Thursday, November 24, 2022APPLICATION FILING RECEIPT MAILED
Sunday, November 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB